New telehealth program aims to help brain injury patients lose weight

NCT ID NCT05699772

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a weight-loss program delivered via telehealth, specifically designed for people with traumatic brain injury (TBI). The program is adapted from the Diabetes Prevention Program and addresses unique needs of TBI patients. Researchers aim to see if the program helps participants lose weight and improve health markers like blood sugar and cholesterol. The trial includes 85 adults with moderate to severe TBI who are overweight or obese.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Telehealth-delivered Group Lifestyle Balance for people with TBI (tGLB-TBI) - a behavioral weight-loss program

What this could lead to

If successful, this could provide a scalable, accessible weight-loss program tailored for people with traumatic brain injury, helping them lose weight and improve overall health.

What could go wrong

This is a small, early-stage trial (85 participants) testing a behavioral intervention, so results may not apply to everyone. Weight loss can be challenging, and the program may not work for all individuals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor Scott & White Research Institute

    Dallas, Texas, 75204, United States